| scholarly article | Q13442814 |
| P50 | author | Liliana Schaefer | Q55296508 |
| P2093 | author name string | Lisa R Tannock | |
| Patricia Wilson | |||
| Joel Thompson | |||
| Deepa Taneja | |||
| Bonnie Mitchell | |||
| Katie Brandewie | |||
| P2860 | cites work | Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease | Q34606590 |
| Dyslipidemia and the progression of renal disease in chronic renal failure patients | Q36335367 | ||
| Statins for improving renal outcomes: a meta-analysis | Q36500899 | ||
| Mouse models for atherosclerosis and pharmaceutical modifiers. | Q36836487 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Impact of genetic background on nephropathy in diabetic mice | Q39131103 | ||
| Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. | Q41195672 | ||
| Effects of hypertension and dyslipidemia on the decline in renal function | Q41668265 | ||
| Amelioration of diabetic nephropathy in SPARC-null mice | Q44378918 | ||
| Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice. | Q44690546 | ||
| Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice | Q45085833 | ||
| Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation | Q46241784 | ||
| Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells | Q46458359 | ||
| Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. | Q46570257 | ||
| Effect of statins on the development of renal dysfunction | Q46688235 | ||
| Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure. | Q46737446 | ||
| Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development | Q46885968 | ||
| Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency | Q47714281 | ||
| Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. | Q50888604 | ||
| Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. | Q51555214 | ||
| Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. | Q53846095 | ||
| Intraglomerular lipid deposition in routine biopsies | Q68033816 | ||
| Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE | Q68033830 | ||
| Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency | Q70592813 | ||
| Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases | Q70673116 | ||
| Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis | Q73387161 | ||
| Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency | Q73718901 | ||
| Renal injury in apolipoprotein E-deficient mice | Q74606513 | ||
| Identification of oxidized low density lipoprotein in human renal biopsies | Q77291551 | ||
| LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-beta expression | Q78253163 | ||
| Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice | Q80477528 | ||
| Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor | Q81134085 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P921 | main subject | hyperlipidemia | Q1079120 |
| P304 | page(s) | 1464-1470 | |
| P577 | publication date | 2010-01-28 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice | |
| P478 | volume | 51 |
| Q34608277 | An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects |
| Q52608853 | Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain. |
| Q35536459 | Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance. |
| Q47693851 | Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice |
| Q38088377 | Fenofibrate and the kidney: an overview. |
| Q47768797 | Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition |
| Q35167826 | Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. |
| Q51348247 | Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats. |
| Q38120646 | Role of dyslipidemia in patients with chronic kidney disease |
| Q38510757 | The ACACB gene rs2268388 polymorphism is associated with nephropathy in Caucasian patients with diabetes: a meta-analysis |
Search more.